See original article from Densitas Densitas launches Canadian-developed technology for breast density assessment CHICAGO, Illinois – December 1, 2015 – Densitas Inc. today announced it has received the CE Mark from the European Commission and a medical device license from Health Canada for its flagship product, DM-Density. These regulatory clearances allow Densitas to begin sales…

2015 © Copyright - Bionova